Sinofn Health
Sinofn Health
The global nutraceutical landscape is undergoing a paradigm shift. As consumer demand trends toward higher bioavailability and personalized nutrition, liquid vitamin formulations have emerged as the gold standard for efficacy and ease of consumption. At SINOFN, we are at the forefront of this evolution, blending scientific rigor with industrial-scale manufacturing.
Modern consumers demand more than just ingredients; they demand results. Our R&D team leverages advanced micro-encapsulation and liquid dispersion technologies to ensure that fat-soluble vitamins (A, D, E, K) and complex nutrients are delivered effectively. By optimizing pH levels and stabilization agents, we offer shelf-stable solutions that retain 99% potency, addressing the core challenges of conventional liquid formulations.
In an era of global volatility, supply chain stability is a competitive advantage. SINOFN’s "Factory 4.0" approach utilizes AI-driven process controls, blockchain batch tracking, and fully automated packaging lines. This digital transformation reduces human error, ensures stringent compliance with HACCP and FSSC 22000, and enables us to scale from pilot batch prototyping to massive retail distribution seamlessly.
Founded in 2012 and anchored by a legacy of cooperation with the Chinese Academy of Sciences, SINOFN Health Co., Ltd. represents the synthesis of clinical research and manufacturing power. We transitioned from specialized PKU (Phenylketonuria) dietary support to a comprehensive global OEM/ODM provider. Our leadership, spearheaded by Mrs. GuoHong Liu, ensures that "Profit with Purpose" remains our guiding philosophy—allocating a portion of revenues to improve accessibility to specialized clinical nutrition.
Our Tianjin R&D center is managed by top-tier medical doctors and post-doctoral experts. From Dr. Tan Shengjie’s 15+ years in metabolic formulations to Dr. Hans van Dijk’s expertise in EU regulatory delivery systems, our team ensures that every ODM partnership receives professional, compliant, and market-ready documentation.
Our operations are centrally managed from Shanghai, with advanced manufacturing and R&D centers in Tianjin, equipped with global-standard production lines to serve international markets.
Yes. We offer pilot-scale prototyping for tablets, capsules, and liquids. Our formulation directors work directly with your team to optimize bioavailability before full-scale production runs.
We provide tailored solutions for both, offering flexible MOQs for startups and high-capacity, automated lines for multinational enterprises, ensuring quality remains constant regardless of volume.
